A prospective, double-blind, randomized trial of midazolam versus haloperidol versus lorazepam in the chemical restraint of violent and severely agitated patients
- PMID: 15231461
- DOI: 10.1197/j.aem.2003.06.015
A prospective, double-blind, randomized trial of midazolam versus haloperidol versus lorazepam in the chemical restraint of violent and severely agitated patients
Abstract
Objectives: To determine if midazolam is superior to lorazepam or haloperidol in the management of violent and severely agitated patients in the emergency department. Superiority would be determined if midazolam resulted in a significantly shorter time to sedation and shorter time to arousal.
Methods: This was a randomized, prospective, double-blind study of a convenience sample of patients from an urban, county teaching emergency department. Participants included 111 violent and severely agitated patients. Patients were randomized to receive intramuscular midazolam (5 mg), lorazepam (2 mg), or haloperidol (5 mg).
Results: The mean (+/-SD) age was 40.7 (+/-13) years. The mean (+/-SD) time to sedation was 18.3 (+/-14) minutes for patients receiving midazolam, 28.3 (+/-25) minutes for haloperidol, and 32.2 (+/-20) minutes for lorazepam. Midazolam had a significantly shorter time to sedation than lorazepam and haloperidol (p < 0.05). The mean difference between midazolam and lorazepam was 13.0 minutes (95% confidence interval [95% CI] = 5.1 to 22.8 minutes) and that between midazolam and haloperidol was 9.9 minutes (95% CI = 0.5 to 19.3 minutes). Time to arousal was 81.9 minutes for patients receiving midazolam, 126.5 minutes for haloperidol, and 217.2 minutes for lorazepam. Time to arousal for midazolam was significantly shorter than for both haloperidol and lorazepam (p < 0.05). The mean difference in time to awakening between midazolam and lorazepam was 135.3 minutes (95% CI = 89 to 182 minutes) and that between midazolam and haloperidol was 44.6 minutes (95% CI = 9 to 80 minutes). There was no significant difference over time by repeated-measures analysis of variance between groups in regard to changes in systolic and diastolic blood pressure (p = 0.8965, p = 0.9581), heart rate (p = 0.5517), respiratory rate (p = 0.8191), and oxygen saturation (p = 0.8991).
Conclusions: Midazolam has a significantly shorter time to onset of sedation and a more rapid time to arousal than lorazepam or haloperidol. The efficacies of all three drugs appear to be similar.
Similar articles
-
Prehospital Agitation and Sedation Trial (PhAST): A Randomized Control Trial of Intramuscular Haloperidol versus Intramuscular Midazolam for the Sedation of the Agitated or Violent Patient in the Prehospital Environment.Prehosp Disaster Med. 2015 Oct;30(5):491-5. doi: 10.1017/S1049023X15004999. Epub 2015 Sep 1. Prehosp Disaster Med. 2015. PMID: 26323511 Clinical Trial.
-
Prospective study of haloperidol plus lorazepam versus droperidol plus midazolam for the treatment of acute agitation in the emergency department.Am J Emerg Med. 2022 May;55:76-81. doi: 10.1016/j.ajem.2022.02.042. Epub 2022 Feb 25. Am J Emerg Med. 2022. PMID: 35287091
-
Intramuscular Midazolam, Olanzapine, Ziprasidone, or Haloperidol for Treating Acute Agitation in the Emergency Department.Ann Emerg Med. 2018 Oct;72(4):374-385. doi: 10.1016/j.annemergmed.2018.04.027. Epub 2018 Jun 7. Ann Emerg Med. 2018. PMID: 29885904
-
The pharmacological management of agitated and aggressive behaviour: A systematic review and meta-analysis.Eur Psychiatry. 2019 Apr;57:78-100. doi: 10.1016/j.eurpsy.2019.01.014. Epub 2019 Feb 2. Eur Psychiatry. 2019. PMID: 30721802
-
Is Ketamine an Effective Treatment of Acute Agitation in the Emergency Department? Implications for APRN Practice.Adv Emerg Nurs J. 2023 Oct-Dec 01;45(4):253-259. doi: 10.1097/TME.0000000000000479. Adv Emerg Nurs J. 2023. PMID: 37885076 Review.
Cited by
-
Organisational interventions for preventing and minimising aggression directed towards healthcare workers by patients and patient advocates.Cochrane Database Syst Rev. 2020 Apr 29;4(4):CD012662. doi: 10.1002/14651858.CD012662.pub2. Cochrane Database Syst Rev. 2020. PMID: 32352565 Free PMC article.
-
Treatment of pediatric behavioral health patients with intravenous and intramuscular chemical restraints: Results from a nationwide sample of emergency departments.Acad Emerg Med. 2023 Oct;30(10):1029-1038. doi: 10.1111/acem.14754. Epub 2023 Jun 19. Acad Emerg Med. 2023. PMID: 37259900 Free PMC article.
-
Disinhibiting neurons in the dorsomedial hypothalamus delays the onset of exertional fatigue and exhaustion in rats exercising in a warm environment.Brain Res. 2018 Jun 15;1689:12-20. doi: 10.1016/j.brainres.2018.03.026. Epub 2018 Mar 22. Brain Res. 2018. PMID: 29577887 Free PMC article.
-
Rapid Tranquilization for Psychiatric Patients with Psychomotor Agitation: What is Known About it?Psychiatr Q. 2017 Dec;88(4):885-895. doi: 10.1007/s11126-017-9504-0. Psychiatr Q. 2017. PMID: 28275892
-
Effect of Intramuscular Ketamine versus Haloperidol on Short-Term Control of Severe Agitated Patients in Emergency Department; A Randomized Clinical Trial.Bull Emerg Trauma. 2018 Oct;6(4):292-299. doi: 10.29252/beat-060404. Bull Emerg Trauma. 2018. PMID: 30402516 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources